Mitsubishi Tanabe Pharma Canada (MTP-CA) Mitsubishi Tanabe Pharma Canada (MTP-CA) - Mobile
  • Français
  • Home
  • About Us
  • Science
  • Our People
  • Media Center
  • Contact Us
  • Resources
  • Careers
  • Global Site

You are now leaving Mitsubishi Tanabe Pharma Canada and visiting a third-party website.

Cancel Continue

If you are interested in exploring careers at MTP-CA, please email
contact@mt-pharma-ca.com.

Close
  • Mitsubishi Tanabe Pharma Canada, Inc. To Discontinue Radicava® IV (Edaravone)

  • Mitsubishi Tanabe Pharma Canada Announces That Company’s Oral Treatment Formulation For Amyotrophic Lateral Sclerosis (Als) Has Been Added To The Provincial Drug Plan In Manitoba

  • Mitsubishi Tanabe Pharma Canada Announces Oral Treatment Formulation For Amyotrophic Lateral Sclerosis (Als) Now Eligible For Coverage Through Veteran Affairs Canada And Indigenous Services Canada

  • Mitsubishi Tanabe Pharma Canada Celebrates Five Years in Canada Supporting and Committed to People Living with ALS

  • Mitsubishi Tanabe Pharma Canada Announces that Company’s Oral Treatment Formulation for Amyotrophic Lateral Sclerosis (ALS) Has Been Added to the Provincial Drug Plans in Prince Edward Island, Newfoundland and Labrador

  • Canadian-Developed AI Technology Aims to Support Early Detection of ALS

  • Mitsubishi Tanabe Pharma Canada Announces that Company’s Oral Treatment Formulation for Amyotrophic Lateral Sclerosis (ALS) has been Added to the Provincial Drug Plans in Saskatchewan

  • Mitsubishi Tanabe Pharma Canada Announces that Company’s Oral Treatment Formulation for Amyotrophic Lateral Sclerosis (ALS) has been Added to the Provincial Drug Plans in New Brunswick and Nova Scotia

  • Mitsubishi Tanabe Pharma Canada Announces that Company’s Oral Treatment Formulation for Amyotrophic Lateral Sclerosis (ALS) has been Added to the Provincial Drug Plan in British Columbia

  • Mitsubishi Tanabe Pharma Canada Announces that Company’s Oral Treatment Formulation for Amyotrophic Lateral Sclerosis (ALS) has been Added to the Provincial Drug Plan in Québec

Mitsubishi Tanabe Pharma America
OUR COMPANY
  • About Us
  • Science
  • Our People
RESOURCES
  • Medical Inquiries
MEDIA
  • Media Center
CONNECT WITH US
  • Global Site
  • Contact Us
  • Careers
  • Terms of Use
  • Compliance
  • Privacy Policy
© Mitsubishi Tanabe Pharma Canada 2019    CNP-CA-0001 06/20
The Mitsubishi Tanabe Pharma Canada logo is a trademark of Mitsubishi Tanabe Pharma Corporation, used under license.